Chris Shield > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
Kirkland & Ellis International LLP
30 ST MARY AXE
LONDON
EC3A 8AF
England
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Chris Shield
020 7469 2025 christopher.shield@kirkland.com
Work Department
Debt Finance
Position
Christopher Shield is a partner in the banking and finance department of the London office of Kirkland & Ellis International LLP. Christopher has banking and debt finance experience including domestic and cross-border syndicated lending, leverage acquisitions, investment grade lending and general banking.
Career
2009 to present Kirkland & Ellis International LLP; 2008-2009 Allen & Overy LLP; 2005-2008 DLA Piper UK LLP.
Memberships
Law Society of England and Wales
Education
College of Law, York (Post Graduate Certificate in Legal Practice, 2003); Queen Mary College, University of London (LL.B. 2002)
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium